Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Palomaki

Showing results (111-120 of 275) with videos related to

Pageof 28
Sort By:
Archives of Pathology & Laboratory Medicine|July 2, 2013
Screening for down syndrome in the United States: results of surveys in 2011 and 2012Glenn E Palomaki, George J Knight, Edward R Ashwood, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 17, 2006
Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old womenGlenn E Palomaki, Monica R McClain, Klaus Steinort, et al.
Nature|March 15, 2013
Coherent state transfer between itinerant microwave fields and a mechanical oscillatorT A Palomaki, J W Harlow, J D Teufel, et al.
Journal of Medical Screening|April 12, 2002
Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndromeG E Palomaki, L A Bradley, G J Knight, et al.
Obstetrics and Gynecology|November 1, 1994
Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defectsD N Saller, J A Canick, G E Palomaki, et al.
Clinical Chemistry|November 4, 1998
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studiesW Y Craig, L M Neveux, G E Palomaki, et al.
Journal of Medical Screening|July 19, 2021
Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 2020Nathalie Lepage, Philip Wyatt, Edward R Ashwood, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
Is maternal plasma DNA testing impacting serum-based screening for aneuploidy in the United States?Glenn E Palomaki, Edward R Ashwood, Robert G Best, et al.
Prenatal Diagnosis|June 19, 2003
Cystic fibrosis: selecting the prenatal screening strategy of choiceN J Wald, J K Morris, C H Rodeck, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 31, 1993
The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase responseT B Ledue, L M Neveux, G E Palomaki, et al.
Pageof 28

Showing results (111-120 of 275) with videos related to

Sort By:
Pageof 28
Archives of Pathology & Laboratory Medicine|July 2, 2013
Screening for down syndrome in the United States: results of surveys in 2011 and 2012Glenn E Palomaki, George J Knight, Edward R Ashwood, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 17, 2006
Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old womenGlenn E Palomaki, Monica R McClain, Klaus Steinort, et al.
Nature|March 15, 2013
Coherent state transfer between itinerant microwave fields and a mechanical oscillatorT A Palomaki, J W Harlow, J D Teufel, et al.
Journal of Medical Screening|April 12, 2002
Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndromeG E Palomaki, L A Bradley, G J Knight, et al.
Obstetrics and Gynecology|November 1, 1994
Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defectsD N Saller, J A Canick, G E Palomaki, et al.
Clinical Chemistry|November 4, 1998
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studiesW Y Craig, L M Neveux, G E Palomaki, et al.
Journal of Medical Screening|July 19, 2021
Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 2020Nathalie Lepage, Philip Wyatt, Edward R Ashwood, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
Is maternal plasma DNA testing impacting serum-based screening for aneuploidy in the United States?Glenn E Palomaki, Edward R Ashwood, Robert G Best, et al.
Prenatal Diagnosis|June 19, 2003
Cystic fibrosis: selecting the prenatal screening strategy of choiceN J Wald, J K Morris, C H Rodeck, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 31, 1993
The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase responseT B Ledue, L M Neveux, G E Palomaki, et al.
Pageof 28